Evidence mapPaperPMID 42549741Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2026

ZHX2 Alleviates Vascular Remodeling and Smooth Muscle Cell Proliferation by Transcriptional Regulation of GADD45G.

Siyuan Fan, Xuelian Wu, Lin Gui, Yichen Wu, Baoru Qiao, Yue Li, Zhe Zheng, Kai Huang

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Siyuan FanCardiovascular Center, Tongji Medical College, Liyuan Hospital, Huazhong University of Science and Technology, Wuhan, China.
Xuelian WuCardiovascular Center, Tongji Medical College, Liyuan Hospital, Huazhong University of Science and Technology, Wuhan, China.ORCID https://orcid.org/0009-0008-4994-6266
Lin GuiCardiovascular Center, Tongji Medical College, Liyuan Hospital, Huazhong University of Science and Technology, Wuhan, China.
Yichen WuClinic Center of Human Gene Research, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China.
Baoru QiaoDepartment of Vascular Surgery, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China.
Yue LiDepartment of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zhe ZhengDepartment of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Kai HuangCardiovascular Center, Tongji Medical College, Liyuan Hospital, Huazhong University of Science and Technology, Wuhan, China.

Funding

The Medical Science and Technology Program of Henan Province LHGJ20220286The Medical Science and Technology Program of Henan Province LHGJ20220297The National Natural Science Foundation of China 81830014The National Natural Science Foundation of China 82200953The National Natural Science Foundation of China 91949201
6 · The paper itself

Abstract

Based on findings from human atherosclerotic arteries and mouse arterial injury models, where ZHX2 expression is significantly downregulated, this study identifies ZHX2 as a critical inhibitor of pathological vascular remodeling. Functionally, local adenoviral overexpression of ZHX2 in vivo attenuates neointima formation in a mouse carotid artery ligation model, while in vitro experiments demonstrate that ZHX2 impedes the proliferation and migration of primary Vascular Smooth Muscle Cells (VSMCs). Mechanistically, integrated RNA-seq and ChIP-seq analyses reveal that ZHX2 transcriptionally regulates GADD45G, directly binding to its promoter and activating its transcription. The essential role of this pathway is confirmed by the finding that knockdown of GADD45G counteracts the inhibitory effects of ZHX2 overexpression on VSMC proliferation, migration, and neointima formation. Consequently, the ZHX2/GADD45G signaling axis is highlighted as a potential regulatory pathway in injury-associated neointimal remodeling.

Indexed as

Cell ProliferationGene Expression RegulationHomeodomain ProteinsIntracellular Signaling Peptides and ProteinsMuscle, Smooth, VascularMyocytes, Smooth MuscleTranscription FactorsVascular RemodelingAnimalsCell Cycle ProteinsCell MovementCells, CulturedGADD45 ProteinsHumansMaleMiceCell Cycle ProteinsGADD45GIP1 protein, humanGADD45 ProteinsHomeodomain ProteinsIntracellular Signaling Peptides and ProteinsTranscription Factorsneointimal hyperplasiapathological vascular diseasestherapeutic targetsvascular remodelingvascular smooth muscle cells

Identifiers

PMID42549741
PMCPMC13435344

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.